LTRN
Lantern Pharma Inc.Company with tickers: LTRN
CIK
1763950
CUSIP
51654W101
Shares Outstanding
12,758,872
Website
https://ir.lanternpharma.com
13F Activity (30d)
11 filings
11 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$7,000,000
as of 2021-11-30
· not restated in filings since 2022-05-03
Remaining Authorization
353,667 shares
as of 2022-03-31
· not restated in filings since 2022-05-03
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $499,997 | 10-K, filed 2025-03-27 |
| 2022-12-31 | $2,482,286 | 10-K, filed 2024-03-18 |
| 2021-12-31 | $939,666 | 10-K, filed 2023-03-20 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $0 Δ | 10-K, filed 2024-03-18 |
| 2022-09-30 | $0 Δ | 10-Q, filed 2023-11-08 |
| 2022-06-30 | $0 Δ | 10-Q, filed 2023-08-09 |
| 2022-03-31 | $2,482,286 | 10-Q, filed 2023-05-09 |